Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac vs ketorolac vs placebo for prevention and treatment of ocular inflammation and pain after cataract surgery (European study)
2005-002647-35Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nepafenac in Postoperative ocular inflammation, post-operative ocular pain and cataract (3 arms), sponsored by Alcon Inc. Started Aug 2005; status: completed.
02
Drugs
nepafenac
03
Conditions
Postoperative ocular inflammationpost-operative ocular paincataract
Beyond the preview
Go deeper on 2005-002647-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002647-35.